• 1626 Citations
  • 20 h-Index
20002019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Alessia Tieghi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Primary Myelofibrosis Medicine & Life Sciences
Essential Thrombocythemia Medicine & Life Sciences
Thrombosis Medicine & Life Sciences
Polycythemia Vera Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Thrombocytosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

  • 1626 Citations
  • 20 h-Index
  • 66 Article
  • 2 Letter
3 Citations (Scopus)

GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

Venditti, A., Piciocchi, A., Candoni, A., Melillo, L., Calafiore, V., Cairoli, R., De Fabritiis, P., Storti, G., Salutari, P., Lanza, F., Martinelli, G., Luppi, M., Mazza, P., Martelli, M. P., Cuneo, A., Albano, F., Fabbiano, F., Tafuri, A., Chierichini, A., Tieghi, A. & 17 others, Fracchiolla, N. S., Capelli, D., Foà, R., Alati, C., Sala, E. L., Fazi, P., Vignetti, M., Maurillo, L., Buccisano, F., Del Principe, M. I., Irno-Consalvo, M., Ottone, T., Lavorgna, S., Voso, M. T., Lo-Coco, F., Arcese, W. & Amadori, S., Sep 19 2019, In : Blood. 134, 12, p. 935-945 11 p.

Research output: Contribution to journalArticle

Residual Neoplasm
Acute Myeloid Leukemia
Young Adult
Transplants
Stem cells

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

Palandri, F., Palumbo, G. A., Abruzzese, E., Iurlo, A., Polverelli, N., Elli, E., Bonifacio, M., Bergamaschi, M., Martino, B., Tiribelli, M., Benevolo, G., Tieghi, A., Sgherza, N., Isidori, A., Binotto, G., Crugnola, M., Heidel, F., Cavazzini, F., Bosi, C., Auteri, G. & 10 others, Cattaneo, D., Foà, R., Lemoli, R. M., Cuneo, A., Krampera, M., Bartoletti, D., Cavo, M., Vianelli, N., Breccia, M. & Latagliata, R., 2019, In : Hematological Oncology. 37, 4, p. 418-423

Research output: Contribution to journalArticle

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

Palandri, F., Palumbo, G. A., Abruzzese, E., Iurlo, A., Polverelli, N., Elli, E., Bonifacio, M., Bergamaschi, M., Martino, B., Tiribelli, M., Benevolo, G., Tieghi, A., Sgherza, N., Isidori, A., Binotto, G., Crugnola, M., Heidel, F., Cavazzini, F., Bosi, C., Auteri, G. & 10 others, Cattaneo, D., Foà, R., Lemoli, R. M., Cuneo, A., Krampera, M., Bartoletti, D., Cavo, M., Vianelli, N., Breccia, M. & Latagliata, R., Oct 1 2019, In : Hematological Oncology. 37, 4, p. 418-423 6 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Leukemia
Spleen
INCB018424
Survival
1 Citation (Scopus)

Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib

Breccia, M., Bartoletti, D., Bonifacio, M., Palumbo, G. A., Polverelli, N., Abruzzese, E., Bergamaschi, M., Tieghi, A., Tiribelli, M., Iurlo, A., Cavazzini, F., Sgherza, N., Binotto, G., Isidori, A., D’Adda, M., Crugnola, M., Bosi, C., Heidel, F., Molica, M., Scaffidi, L. & 14 others, Cattaneo, D., Latagliata, R., Auteri, G., Lemoli, R. M., Fanin, R., Russo, D., Aversa, F., Cuneo, A., Semenzato, G., Catani, L., Cavo, M., Vianelli, N., Foà, R. & Palandri, F., 2019, In : Annals of Hematology. 98, 4, p. 889-896

Research output: Contribution to journalArticle

Primary Myelofibrosis
Comorbidity
Body Mass Index
Spleen
Anemia

Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

on behalf of MPN-K authors, Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter